AIMD, BCG and RENB among pre-market losers

seekingalpha05-24

Losers: Verastem (VSTM) -57% rallies on positive data for pancreatic cancer drug combo. Sensei Biotherapeutics (SNSE) -39% presents promising clinical data from Phase 1 Dose Escalation study of SNS-...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2437865039?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-05-24 20:16","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2437865039","market":"hk","top_or_hot":-1,"title":"AIMD, BCG and RENB among pre-market losers","media":"seekingalpha","content":"<div>\n<p>Losers: Verastem (VSTM) -57% rallies on positive data for pancreatic cancer drug combo.\nSensei Biotherapeutics (SNSE) -39% presents promising clinical data from Phase 1 Dose Escalation study of SNS-...</p>\n\n<a href=\"https://seekingalpha.com/news/4110209-aimd-bcg-and-renb-among-pre-market-losers\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AIMD, BCG and RENB among pre-market losers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAIMD, BCG and RENB among pre-market losers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-05-24 20:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4110209-aimd-bcg-and-renb-among-pre-market-losers><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Losers: Verastem (VSTM) -57% rallies on positive data for pancreatic cancer drug combo.\nSensei Biotherapeutics (SNSE) -39% presents promising clinical data from Phase 1 Dose Escalation study of SNS-...</p>\n\n<a href=\"https://seekingalpha.com/news/4110209-aimd-bcg-and-renb-among-pre-market-losers\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2063271972.USD","symbol_name":"富兰克林创新领域基金","start_time":0,"source_url":"https://seekingalpha.com/news/4110209-aimd-bcg-and-renb-among-pre-market-losers","article_id":"2437865039","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2437865039","pubTimestamp":1716552960,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Losers: Verastem -57%rallies on positive data for pancreatic cancer drug combo.Sensei Biotherapeutics  -39%presents promising clinical data from Phase 1 Dose Escalation study of SNS-101.Summit Therapeutics -17%after late-stage data for lead asset.","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2063271972.USD":"富兰克林创新领域基金","BK4528":"SaaS概念","LU2517655291.USD":"WELLINGTON NEXT GENERATION EDUCATION \"A\" (USD) ACC","INTU":"财捷","LU0011850046.USD":"贝莱德全球长线股票 A2 USD","LU2517655374.HKD":"WELLINGTON NEXT GENERATION EDUCATION \"A\" (HKD) ACC","AUUD":"Auddia Inc.","LU0097036916.USD":"贝莱德美国增长A2 USD","LU0511384066.AUD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (AUDHDG) ACC","LU0949170772.SGD":"Blackrock Global Equity Income A6 SGD-H","BK4534":"瑞士信贷持仓","BK4567":"ESG概念","BK4585":"ETF&股票定投概念","LU1046421795.USD":"富达环球科技A-ACC","VSTM":"Verastem","LU1691799644.USD":"Amundi Funds Polen Capital Global Growth A2 (C) USD","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0289961442.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"AX\" (SGD) ACC","SG9999002224.SGD":"Allianz Global High Payout SGD","DOMO":"Domo Inc.","LU0957791311.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"ZU\" (USD) ACC","LU1815333072.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"AUP\" (USD) INC","LU0289739343.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","BCG":"Binah Capital Group Inc","WDAY":"Workday","AIMD":"AINOS Inc.","RENB":"RENOVARO BIOSCIENCES INC","LU1989763005.USD":"东方汇理教育基金A2 Acc","SMMT":"Summit Therapeutics PLC","LU2023251221.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (USD) INC","BK4551":"寇图资本持仓","LU1935043536.SGD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME \"AA\" (SGDHDG) INC A","GB00BDT5M118.USD":"天利环球扩展Alpha基金A Acc","LU0889565833.HKD":"FRANKLIN TECHNOLOGY \"A\" (HKD) ACC","LU1803068979.SGD":"FTIF - Franklin Technology A (acc) SGD-H1","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","LU0719512351.SGD":"JPMorgan Funds - US Technology A (acc) SGD","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","BK4135":"资产管理与托管银行","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","SNSE":"Sensei Biotherapeutics, Inc.","LU2089284900.SGD":"Allianz Global Sustainability Cl AM Dis H2-SGD","LU1935042991.SGD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME  \"AA\" (SGDHDG) INC","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","BK4548":"巴美列捷福持仓","SG9999002232.USD":"Allianz Global High Payout USD","LU0109392836.USD":"富兰克林科技股A","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","LU2517655028.SGD":"WELLINGTON NEXT GENERATION EDUCATION \"A\" (SGDHDG) ACC"},"translate_title":"AIMD、波士顿咨询公司和RENB在盘前输家中","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AUUD":1,"WDAY":1,"VSTM":1,"SNSE":1,"SMMT":1,"RENB":1,"INTU":1,"DOMO":1,"AIMD":1,"BCG":1},"content_text":"Losers: Verastem (VSTM) -57% rallies on positive data for pancreatic cancer drug combo.\nSensei Biotherapeutics (SNSE) -39% presents promising clinical data from Phase 1 Dose Escalation study of SNS-101.\nSummit Therapeutics (SMMT) -17% after late-stage data for lead asset.\nDomo (DOMO) -13% after Q1 earnings release.\nWorkday (WDAY) -11% after Q1 earnings release.\nAinos (AIMD) -7%.\nAuddia (AUUD) -7%.\nBinah Capital Group  (BCG) -7%.\nRenovaro (RENB) -7%.\nIntuit (INTU) -6% after Q3 earnings release.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2437865039"}